Document Detail

Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice.
MedLine Citation:
PMID:  15378017     Owner:  NLM     Status:  MEDLINE    
The control exerted by the INK4a/ARF locus on cellular proliferation is crucial to restrict tumor development. In agreement with this, mice with defects in this locus are highly tumor prone. However, the potential contribution of other pathways in modulating tumorigenesis in the absence of INK4a/ARF is largely unexplored. In the present study, we investigated the consequences of the combined loss of either of two cyclin-dependent kinase inhibitors, p21 and p27, in cooperation with deletion of the INK4a/ARF locus. Our results show a clear differential effect in tumorigenesis depending on the CKI that is absent. The absence of p21 produced no overt alteration of the lifespan of the INK4a/ARF-null mice, although it modified their tumor spectrum, causing a significant increase in the incidence of fibrosarcomas and the appearance of a small number of rhabdomyosarcomas. In contrast, deficiency of p27 resulted in a significant increase in lethality due to accelerated tumor development, especially in the case of T-cell lymphomas. Finally, combined deficiency of INK4a/ARF and p27 resulted in a significant increase in the number of metastatic tumors. These results demonstrate genetically the oncogenic cooperation between defects on INK4a/ARF and p27, which are common alterations in human cancer.
Juan Martín-Caballero; Juana M Flores; Pilar García-Palencia; Manuel Collado; Manuel Serrano
Related Documents :
9671387 - Re-expression of p16ink4a in mesothelioma cells results in cell cycle arrest, cell deat...
17036527 - Phyllodes tumor with osteosarcomatous differentiation: a comparative immunohistochemica...
14985467 - Cyclin-dependent kinase 6 inhibits proliferation of human mammary epithelial cells.
9380407 - Modulation of cell cycle control by vitamin d3 and its analogue, eb1089, in human breas...
17429647 - Measurement by multidetector ct scan of the volume of hypopharyngeal and laryngeal tumo...
9346177 - Apoptosis, bcl-2 protein, and fas antigen in thymic epithelial tumors.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Oncogene     Volume:  23     ISSN:  0950-9232     ISO Abbreviation:  Oncogene     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-10-28     Completed Date:  2004-12-06     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  England    
Other Details:
Languages:  eng     Pagination:  8231-7     Citation Subset:  IM    
Molecular Oncology Program, Spanish National Cancer Center (CNIO), Melchor Fernandez Almagro 3, Madrid E-28029, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
ADP-Ribosylation Factors / genetics*
Cell Cycle Proteins / genetics*
Cyclin-Dependent Kinase Inhibitor p16 / genetics*
Cyclin-Dependent Kinase Inhibitor p21
Cyclin-Dependent Kinase Inhibitor p27
Cyclins / genetics*
Mice, Inbred C57BL
Sequence Deletion*
Tumor Suppressor Proteins / genetics*
Reg. No./Substance:
0/Cdkn1a protein, mouse; 0/Cdkn1b protein, mouse; 0/Cell Cycle Proteins; 0/Cyclin-Dependent Kinase Inhibitor p16; 0/Cyclin-Dependent Kinase Inhibitor p21; 0/Cyclins; 0/Tumor Suppressor Proteins; 147604-94-2/Cyclin-Dependent Kinase Inhibitor p27; EC Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma.
Next Document:  RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and ...